JMP Securities Downgrades Enanta Pharma To Market Perform
July 07, 2014 at 07:45 AM EDT
Analysts at JMP Securities downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) from “market outperform” to “market perform” and removed ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.